Samraat S. Raha
President and CEO at Myriad Genetics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Myriad Genetics Inc., 1 year.
Myriad Genetics Inc.
Director · President and CEO
Chief executive roles
Myriad Genetics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Myriad Genetics Inc. | Grant or award | +3,542 | $3.94 | $13,955 |
| Mar 14, 2026 | Myriad Genetics Inc. | Shares withheld for tax | −10,816 | $4.66 | $50,403 |
| Mar 13, 2026 | Myriad Genetics Inc. | Shares withheld for tax | −36,304 | $4.66 | $169,177 |
| Mar 12, 2026 | Myriad Genetics Inc. | Grant or award | +618,557 | — | — |
| Mar 9, 2026 | Myriad Genetics Inc. | Open-market purchase | +40,000 | $5.00 | $200,000 |
| Dec 11, 2025 | Myriad Genetics Inc. | Shares withheld for tax | −29,634 | $7.30 | $216,328 |
| May 31, 2025 | Myriad Genetics Inc. | Grant or award | +1,498 | $3.56 | $5,333 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.